Edition:
United States

Rigel Pharmaceuticals Inc (RIGL.OQ)

RIGL.OQ on NASDAQ Stock Exchange Global Select Market

2.62USD
17 Aug 2018
Change (% chg)

$-0.08 (-2.96%)
Prev Close
$2.70
Open
$2.69
Day's High
$2.69
Day's Low
$2.59
Volume
465,984
Avg. Vol
727,844
52-wk High
$4.71
52-wk Low
$2.18

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.16 December 18 Aug 2018

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 1 1 1 1
(2) OUTPERFORM 5 5 5 5
(3) HOLD 0 0 0 0
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 1.83 1.83 1.83 1.83

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Sep-18 6 2.48 3.48 1.76 --
Quarter Ending Dec-18 6 3.49 4.83 2.43 --
Year Ending Dec-18 6 7.80 10.10 6.20 26.42
Year Ending Dec-19 6 37.43 46.16 23.10 61.69
Earnings (per share)
Quarter Ending Sep-18 6 -0.16 -0.15 -0.17 --
Quarter Ending Dec-18 6 -0.16 -0.15 -0.18 --
Year Ending Dec-18 6 -0.65 -0.62 -0.67 -0.44
Year Ending Dec-19 6 -0.50 -0.38 -0.64 -0.21

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Jun-18 0.18 1.79 1.61 916.50
Quarter Ending Mar-18 0.05 0.00 0.05 100.00
Quarter Ending Dec-17 0.04 0.00 0.04 100.00
Quarter Ending Sep-17 0.00 0.90 0.90 0.00
Quarter Ending Jun-17 1.56 0.00 1.56 100.00

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Sep-18 2.48 2.48 1.59 1.59 --
Quarter Ending Dec-18 3.49 3.49 3.60 3.60 --
Year Ending Dec-18 7.80 7.80 5.20 5.20 26.42
Year Ending Dec-19 37.43 37.43 45.27 45.27 61.69

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Sep-18 0 0 4 2
Quarter Ending Dec-18 0 0 3 3
Year Ending Dec-18 0 0 5 1
Year Ending Dec-19 0 0 1 5
Earnings